ClinicalTrials.Veeva

Menu

T1 Tissue Mapping as a Non Invasive Biomarker for Quantification of Chronic Thyroid Related Microscopic Myocardial Fibrosis.

A

Assiut University

Status

Not yet enrolling

Conditions

Chronic Thyroid Disease

Study type

Observational

Funder types

Other

Identifiers

NCT07247981
CMR T1 tissue mapping

Details and patient eligibility

About

CMR T1 tissue mapping helps in detection and quantification of the microscopic myocardial fibrosis and is more accurate and non invasive maneuver.

Full description

Chronic thyroid diseased patients either hypo or hyperthyroidism may develop arrhythmias or even atrial fibrillation which is worrisome. And since early detection provides the early management, T1 tissue mapping of the heart provides accurate quantification of the myocardial fibrosis throughout the imaged organ.

Enrollment

40 estimated patients

Sex

All

Ages

18 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • patients with chronic thyroid disease.

Exclusion criteria

  • patients with other chronic illnesses ( diabetes, hypertension, .. etc).
  • patients received neck radiation therapy.

Trial contacts and locations

0

Loading...

Central trial contact

Lina M Farid, MSc; Moustafa A Sayyed, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems